Recommendations for evaluating compliance and persistence with hypertension therapy using retrospective data

被引：158
作者：
Halpern, Michael T.
Khan, Zeba M.
Schmier, Jordana K.
Burnier, Michel
Caro, J. Jaime
Cramer, Joyce
Daley, William L.
Gurwitz, Jerry
Hollenberg, Norman K.
机构：
[1] Exponent, Hlth Sci Grp, Alexandria, VA 22314 USA
[2] Novartis Pharma AG, Basel, Switzerland
[3] Univ Lausanne, CH-1015 Lausanne, Switzerland
[4] Caro Res, Concord, MA USA
[5] Yale Univ, New Haven, CT 06520 USA
[6] Nova Pharmaceut Corp, E Hanover, NJ USA
[7] Univ Massachusetts, Sch Med, Worcester, MA 01605 USA
[8] Harvard Univ, Boston, MA 02115 USA
来源：
HYPERTENSION | 2006年 / 47卷 / 06期
关键词：
D O I：
10.1161/01.HYP.0000222373.59104.3d
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：1039 / 1048
页数：10
相关论文
共 59 条
[1]  
Andrade SE, 2004, AM J MANAG CARE, V10, P481
[2]  
[Anonymous], 2005, INT RISK INF SYST
[3]   Risk factors for antihypertensive medication refill failure by patients under Medicaid managed care [J].
Bailey, JE ;
Lee, MD ;
Somes, GW ;
Graham, RL .
CLINICAL THERAPEUTICS, 1996, 18 (06) :1252-1262
[4]  
[Blood Institute and GINA Executive Committee National Heart Lung], 2004, NIH PUBL, V02-3659
[5]   Electronic compliance monitoring in resistant hypertension:: the basis for rational therapeutic decisions [J].
Burnier, M ;
Schneider, MP ;
Chioléro, A ;
Stubi, CLF ;
Brunner, HR .
JOURNAL OF HYPERTENSION, 2001, 19 (02) :335-341
[6]   Determinants of persistence in hypertensive patients treated with irbesartan: Results of a postmarketing survey [J].
Burnier M. ;
Hess B. ;
Greminger P. ;
Waeber B. .
BMC Cardiovascular Disorders, 5 (1)
[7]  
Caro JJ, 1999, CAN MED ASSOC J, V160, P31
[8]  
Cave D G, 1995, J Ambul Care Manage, V18, P42
[9]  
Celentano Aldo, 2004, Ital Heart J, V5, P767
[10]   Predictors of adherence with antihypertensive and lipid-lowering therapy [J].
Chapman, RH ;
Benner, JS ;
Petrilla, AA ;
Tierce, JC ;
Collins, SR ;
Battleman, DS ;
Schwartz, JS .
ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (10) :1147-1152
123456